Quantify is an experienced partner in health economics, outcomes research, real-world evidence and market access. Our goal is to continuously deliver high quality services, combining our scientific and quantitative skills with a solution-oriented mindset and business focus. We have our roots in academia with a broad competence in value strategy, modeling, evidence generation, biostatistics, study design and analysis.
Through extensive experience within both the governmental and private sectors, we have acquired a dynamic and efficient work model, putting emphasis on communication and finding tailored solutions to fit our clients’ needs.
Services
Make the complex simple
News
Quantify’s Anders Gustavsson co-author of recently published Alzheimer study
Anders Gustavsson is co-author of a recently published Alzheimer study presenting a cross-walk between the generic health utility measure EQ5D and the disease specific health-related quality of life measure QoL-AD.
A free full text version is […]
Quantify’s Anders Gustavsson panelist at HTAi symposium
Anders Gustavsson, Partner at Quantify, is a panelist at a HTAi symposium on the value of delaying progression in early Alzheimer’s disease on October 13, sponsored by Biogen.
See full program on https://htai.eventsair.com/htaibeijing2020/#program.
[…]
QUANTIFY becomes an ENCePP partner
Coordinated by EMA, the European Network of Centers for Pharmacoepidemiology & Pharmacovigilance (ENCePP) is an initiative that brings together expertise and resources in pharmacoepidemiology and pharmacovigilance across Europe with the aim to facilitate the conduct […]
